Form 4: Genprex CMO's RSU Vesting Leads to Tax Withholding

Genprex's Chief Medical Officer, Mark Stanley Berger, reported a disposition of 7,168 common shares for tax obligations related to RSU vesting.

Summary

• Mark Stanley Berger, Chief Medical Officer of Genprex, Inc., reported a transaction on February 27, 2026.
• The transaction involved the disposition of 7,168 shares of Genprex Common Stock.
• These shares were withheld to satisfy tax withholding obligations associated with the vesting of previously granted Restricted Stock Units (RSUs).
• The RSUs were granted under the Genprex, Inc. 2018 Equity Incentive Plan, which was amended and restated effective June 30, 2025.
• Following this transaction, Mark Stanley Berger directly beneficially owns 21,692 shares of Common Stock.
• The deemed price for the shares withheld was $2.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine administrative transaction related to executive compensation rather than a strategic move or a reflection of company performance.

Positives

• The vesting of Restricted Stock Units indicates that previously granted equity incentives are maturing, which can be a positive sign of employee retention and long-term commitment.

Future Outlook

No forward-looking statements or guidance are provided in this Form 4 filing.

Industry Context

StockSavvy.ai notes that routine Form 4 filings detailing RSU vesting and associated tax withholdings are common across all industries for publicly traded companies, reflecting standard executive compensation practices and equity incentive plans. This specific filing does not provide broader industry insights.

Comparison to Industry Standards

• This is a standard insider transaction for tax withholding on RSU vesting, a common practice in executive compensation across publicly traded companies. For example, similar transactions are routinely reported by executives at biotech firms like Amgen (AMGN) or Gilead Sciences (GILD) when their equity awards vest, aligning with typical compensation structures designed to incentivize long-term performance.

Related Party Transactions

• This filing details an insider transaction (tax withholding for RSU vesting) which is a form of related party transaction, but it is a standard compensation event rather than a unique dealing.

Stakeholder Impact

• Shareholders: Minimal direct impact. This is a routine administrative transaction and does not signal a change in company fundamentals or strategy. It slightly reduces the reporting person's direct ownership but is offset by the prior grant of RSUs.
• Employees: Reflects the ongoing operation of the company's equity incentive plan, which can be a positive for employee morale regarding compensation.

Key Dates

Keywords

Genprex, GNPX, Form 4, insider transaction, RSU vesting, tax withholding, equity incentive plan, Mark Stanley Berger, Chief Medical Officer